Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial

Saved in:
Bibliographic Details
Main Authors: Akihiro Hirakawa, Masahiko Ando, Masahiro Hayakawa, Nao Matsuyama, Shinobu Shimizu, Kazuto Ueda, Toshihiko Suzuki, Sakiko Suzuki, Ryosuke Miura, Akemi Katayama, Masaaki Mizuno, Yoshiaki Sato
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 2022-04-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/4/e057073.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items